PharmaNet Development Group, Inc. Experts to Share Insights at the 9th Annual Partnerships in Clinical Trials Conference in Vienna
At the conference, members of PharmaNet's management team will discuss the opportunities and challenges currently facing the CRO industry, including the impact of the economic environment on drug development and the need for innovative collaboration in post-marketing studies and biosimilar development.
Wednesday 17 November 2010
Dalvir Gill, PhD, President, Late Stage Development, will give a keynote presentation, "Surviving Difficult Times: How Much Has the Recession Really Affected Clinical Outsourcing and How Does the Industry Need to Change?"
Jeff Trotter, Executive Vice President, Phase IV Development, will present "Successful Approaches to Partnering in Post-Marketing Studies."
Thursday 18 November 2010
Dr. Pablo Fernandez, LMS, FFPM, Senior Vice President, Medical Affairs, will present "Partnering to Overcome the Challenges of Biosimilar Development."
Conference attendees can learn more about PharmaNet's capabilities by visiting booth 129 in the exhibition hall where an international team of representatives will be available to discuss PharmaNet's expertise in helping clients reach their goal of delivering safe and effective therapeutics to patients.
About PharmaNet Development Group, Inc.
PharmaNet Development Group, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com.
Contact: Anne-Marie Hess | |
Phone: (609) 951-6842 | |
E-mail: ahess@pharmanet.com | |
SOURCE PharmaNet Development Group, Inc.